Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,030 across all filing types
Latest filing 2022-08-05 AGM Information
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Result of Annual General Meeting
AGM Information
2022-08-05 English
Autolus Reports Q2 2022 Financial Results
Report Publication Announcement Classification · 95% confidence The document is a regulatory announcement (RNS) issued by Syncona Limited regarding its portfolio company, Autolus Therapeutics. It serves as a notification that Autolus has released its Q2 2022 financial results. While the document contains substantive financial data and operational updates for Autolus, it is presented as an announcement of a report rather than the primary financial report itself. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA). Q2 2022
2022-08-04 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 8129U' and contains the standard formatting and content of a regulatory notification disseminated via the London Stock Exchange's RNS service. Specifically, the form title is 'TR-1: Standard form for notification of major holdings,' which details changes in voting rights held by a shareholder (Sarasin & Partners LLP). This type of filing reports changes in significant share ownership, which corresponds directly to the 'Major Shareholding Notification' definition (MRQ). Although it is an RNS filing, MRQ is the more specific category for major holding changes.
2022-08-03 English
Result of AGM
AGM Information Classification · 100% confidence The document is titled 'Result of Annual General Meeting' and explicitly details the voting outcomes for various resolutions (Ordinary, Special, Extraordinary) presented at the AGM held on August 2, 2022. This content directly corresponds to the reporting of voting results from a general meeting. This matches the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it mentions the Annual Audited Financial Statements (Resolution 1), the primary purpose and content of this specific filing is the vote tally, not the full financial report (10-K) or the management discussion (MDA).
2022-08-02 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement (2804 characters) identified by the 'RNS Number' header and the footer indicating it is provided by RNS, the news service of the London Stock Exchange. The content explicitly states the 'Total Voting Rights' as of a specific date (2 August 2022) and provides the total number of ordinary shares in issue. This type of mandatory disclosure regarding the total number of shares and voting rights, often referencing DTR 5.6.1, is a standard regulatory filing. Since there is no specific category for 'Total Voting Rights' announcements, and it is a general regulatory update provided via RNS, it best fits the 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous regulatory announcements not covered by more specific codes like DIRS or DIV.
2022-08-02 English
Issue of shares pursuant to incentive scheme
Share Issue/Capital Change Classification · 99% confidence The document is an RNS announcement dated July 15, 2022, detailing the 'Issue of shares pursuant to incentive scheme and PDMR dealings'. It specifically reports transactions (share issues) by Persons Discharging Managerial Responsibilities (PDMRs) like the CEO and CIO. This content directly aligns with the definition of Director's Dealing (insider trades) and is a regulatory filing type. Since the core content is the notification of insider transactions, the most specific code is DIRS. While it is distributed via RNS, DIRS is a more precise classification than the general RNS fallback.
2022-07-15 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.